The Journal of urology

publication venue for

The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. 1993
Reply by Authors. 2024
Reply by Authors. 2024
Gabapentin for Post-operative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical Trial. 2024
Timing of Testicular Biopsy in Relation to Oocyte Retrieval and the Outcomes of Intracytoplasmic Sperm Injection. 2024
Comparative Analyses and Ablation Efficiency of Thulium Fiber Laser by Stone Composition. 2023
Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome. 2023
Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma.. 211. 2023
Same-day Discharge versus Inpatient Robotic Assisted Radical Prostatectomy: Complications, Time-Driven Activity-Based Costing, and Patient Satisfaction. 2023
Clinically Important Differences for Pain and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study. 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.. 209. 2023
Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial.. 209. 2023
Utility of MRI for Localizing Prostate Cancer near the Urethra in Men Who are Candidates for Focal Gland Ablation. 2023
Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference? 2023
Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification.. 209. 2022
Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study.. 209. 2022
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma.. 209. 2022
National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. 2022
First Series Using Ultrasonic Propulsion and Burst Wave Lithotripsy to Treat Ureteral Stones.. 208. 2022
Impact of Left-digit Age Bias in the Treatment of Localized Prostate Cancer. 2022
Effects of Chemo- and Radiation Therapy on Microsurgical Testicular Sperm Extraction for Men with Non-obstructive Azoospermia. 2022
ALDH2 Expression, Alcohol Intake and Semen Parameters among East Asian Men.. 208. 2022
Is Pelvic Floor Muscle Tenderness a Distinct Urologic Chronic Pelvic Pain Syndrome (UCPPS) Phenotype?: Findings From the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Symptoms Pattern Study (SPS). 2022
Reliability and Validity of Pain and Urinary Symptom Severity Assessment in Urological Chronic Pelvic Pain: A MAPP Network Analysis.. 207. 2022
Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide.. 207. 2022
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report. 2021
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer.. 207. 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.. 207. 2021
Primary Chemoablation of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Using UGN-102, A Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial. 2021
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium. 2021
Quantifying Heterogeneity of Testicular Histopathology in Men with Nonobstructive Azoospermia. 2021
Comparative Outcomes of Salvage Retzius-Sparing versus Standard Robotic Prostatectomy: An International, Multi-Surgeon Series. 2021
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy. 2021
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy.. 206. 2021
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies.. 206. 2021
Sarcopenic Obesity and its Prognostic Impact on Urological Cancers: A Systematic Review.. 206. 2021
Standing Ultrasound Adds Clinical Utility for the Diagnosis of Varicoceles.. 206. 2021
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice.. 206. 2021
Adoption, Safety, and Retreatment Rates of Prostatic Urethral Lift for Benign Prostatic Enlargement.. 206. 2021
Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer.. 206. 2021
A Systematic Review and Scoping Analysis of Smoking Cessation after a Urological Cancer Diagnosis.. 205. 2021
Temporal Relationships between Pain, Mood and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study.. 205. 2021
Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria.. 205. 2020
Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data.. 205. 2020
Safety and Efficacy of Outpatient Surgical Procedures for the Treatment of Benign Prostatic Enlargement in New York State and California (2005-2016).. 205. 2020
Efficacy of Daily Intake of Dried Cranberry 500 mg in Women with Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled Study.. 205. 2020
Long-Term Safety with Sling Mesh Implants for Stress Incontinence.. 205. 2020
Active Surveillance for Men with Intermediate Risk Prostate Cancer.. 205. 2020
Correlates of 1-Year Change in Quality of Life in Patients with Urologic Chronic Pelvic Pain Syndrome: Findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.. 204. 2020
Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities.. 204. 2020
Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate.. 204. 2020
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of ⁶⁸Ga-PSMA and ¹¹C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections.. 204. 2020
Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.. 203. 2020
Extraperitoneal versus Transperitoneal Single Port Robotic Radical Prostatectomy: A Comparative Analysis of Perioperative Outcomes.. 203. 2019
The Balance between Open and Robotic Training among Graduating Urology Residents-Does Surgical Technique Need Monitoring?. 203. 2019
Sperm Genomic Integrity by TUNEL Varies throughout the Male Genital Tract.. 203. 2019
Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.. 203. 2019
Predictors of Psychosocial Distress in Parents of Young Children with Disorders of Sex Development.. 202. 2019
SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer.. 202. 2019
PTEN Loss with ERG Negative Status is Associated with Lethal Disease after Radical Prostatectomy.. 203. 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop.. 203. 2019
Variation in Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Outcomes in Asian American Men: A Multicenter Study.. 203. 2019
Association between Inflammatory Potential of Diet and Bladder Cancer Risk: Results of 3 United States Prospective Cohort Studies.. 202. 2019
Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer.. 202. 2019
Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder: Focus on Safety and Cost.. 203. 2019
Association of Smoking and Death from Genitourinary Malignancies: Analysis of the National Longitudinal Mortality Study.. 202. 2019
Kidney Stones and Risk of Narcotic Use.. 202. 2019
The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer.. 202. 2019
Long-Term Implications of a Positive Posttreatment Biopsy in Patients Treated with External Beam Radiotherapy for Clinically Localized Prostate Cancer.. 201. 2019
Robotic Davydov Peritoneal Flap Vaginoplasty for Augmentation of Vaginal Depth in Feminizing Vaginoplasty.. 201. 2019
Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer.. 201. 2019
The Kinetics of Sperm Return and Late Failure Following Vasovasostomy or Vasoepididymostomy: A Systematic Review.. 201. 2019
A Contemporary Analysis of Dual Inflatable Penile Prosthesis and Artificial Urinary Sphincter Outcomes.. 201. 2019
Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer.. 201. 2019
cT1a Renal Masses Less Than 2 versus 2 cm or Greater Managed by Robotic Partial Nephrectomy: A Propensity Score Matched Comparison of Perioperative Outcomes.. 201. 2019
Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness.. 200. 2018
Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study.. 200. 2018
Multiple Regions of Interest on Multiparametric Magnetic Resonance Imaging are Not Associated with Increased Detection of Clinically Significant Prostate Cancer on Fusion Biopsy.. 200. 2018
Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging.. 200. 2018
Correlates of Health Care Seeking Activities in Patients with Urological Chronic Pelvic Pain Syndromes: Findings from the MAPP Cohort.. 200. 2018
Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies.. 199. 2018
Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?. 199. 2018
A Case-Crossover Study of Urological Chronic Pelvic Pain Syndrome Flare Triggers in the MAPP Research Network.. 199. 2017
Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases.. 199. 2017
Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer Studies.. 199. 2017
Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection.. 199. 2017
Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.. 199. 2017
Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.. 199. 2017
Depressive Symptoms and Low Sexual Desire after Radical Prostatectomy: Early and Long-Term Outcomes in a Real-Life Setting.. 199. 2017
Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.. 199. 2017
Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer.. 199. 2017
Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.. 198. 2017
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma.. 198. 2017
Predictors of Hospital Admission and Urological Intervention in Adult Emergency Department Patients with Computerized Tomography Confirmed Ureteral Stones.. 198. 2017
Microsurgically Assisted Inguinal Hernia Repair and Simultaneous Male Fertility Procedures: Rationale, Technique and Outcomes.. 198. 2017
Contemporary Patterns of Care and Outcomes of Men Found to Have Lymph Node Metastases at the Time of Radical Prostatectomy.. 198. 2017
Clinical and Psychosocial Predictors of Urological Chronic Pelvic Pain Symptom Change in 1 Year: A Prospective Study from the MAPP Research Network.. 198. 2017
Psychological Adjustment of Parents of Children Born with Atypical Genitalia 1 Year after Genitoplasty.. 198. 2017
Challenging the Myth: Transvaginal Mesh is Not Associated with Carcinogenesis.. 198. 2017
Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.. 198. 2017
Characterization of Whole Body Pain in Urological Chronic Pelvic Pain Syndrome at Baseline: A MAPP Research Network Study.. 198. 2017
Clinical Outcomes in Patients with Panurothelial Carcinoma Treated with Radical Nephroureterectomy Following Cystectomy for Metachronous Recurrence.. 198. 2017
Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.. 198. 2017
Resurfacing the Penis of Complex Hypospadias Repair ("Hypospadias Cripples").. 197. 2017
Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter Study.. 198. 2017
Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.. 197. 2016
Ultrasonographic Assessment of Testicular Viability Using Heterogeneity Levels in Torsed Testicles.. 197. 2016
Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study.. 197. 2016
Patient Function and the Value of Surgical Care for Kidney Cancer.. 197. 2016
Development and Validation of an Objective Scoring Tool for Robot-Assisted Radical Prostatectomy: Prostatectomy Assessment and Competency Evaluation.. 197. 2016
Indications, Utilization and Complications Following Prostate Biopsy: New York State Analysis.. 197. 2016
Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial.. 197. 2016
Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel.. 197. 2016
Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.. 197. 2016
Comparative Effectiveness of Cancer Control and Survival after Robot-Assisted versus Open Radical Prostatectomy.. 197. 2016
Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate Cancer.. 197. 2016
Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma.. 197. 2016
Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.. 197. 2016
Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.. 197. 2016
Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts.. 197. 2016
Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm.. 197. 2016
Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology.. 197. 2016
Retroperitoneal Lymph Node Dissection: Anatomical and Technical Considerations from a Cadaveric Study.. 196. 2016
Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States.. 196. 2016
Factors Impacting the Occurrence of Local, Distant and Atypical Recurrences after Robot-Assisted Radical Cystectomy: A Detailed Analysis of 310 Patients.. 196. 2016
External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC.. 196. 2016
Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.. 196. 2016
Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.. 196. 2016
Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate Biopsy.. 196. 2016
A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor.. 196. 2016
Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study.. 196. 2016
Life Expectancy and Variation in Treatment for Early Stage Kidney Cancer.. 196. 2016
Nerve Sparing Clitoroplasty is an Option for Adolescent and Adult Female Patients with Congenital Adrenal Hyperplasia and Clitoral Pain following Prior Clitoral Recession or Incomplete Reduction.. 195. 2016
The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.. 196. 2016
Erectile Function Recovery after Radical Prostatectomy in Men with High Risk Features.. 196. 2016
Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine.. 196. 2016
Dynamic Prognostication Using Conditional Recurrence and Progression Estimates for Patients with Nonmuscle Invasive Bladder Cancer.. 196. 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma.. 195. 2016
Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.. 196. 2015
Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.. 195. 2015
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter.. 195. 2015
Multi-Institutional Experience with Robotic Nephrectomy with Inferior Vena Cava Tumor Thrombectomy.. 195. 2015
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer.. 195. 2015
The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.. 195. 2015
External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy.. 195. 2015
Risk of Vascular Toxicity with Platinum Based Chemotherapy in Elderly Patients with Bladder Cancer.. 195. 2015
Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma.. 195. 2015
Pelvic Organ Prolapse in Female Patients Presenting to Transitional Urology Care Clinic.. 194. 2015
Characterizing Early Psychosocial Functioning of Parents of Children with Moderate to Severe Genital Ambiguity due to Disorders of Sex Development.. 194. 2015
Multi-Institutional Validation of Fundamental Inanimate Robotic Skills Tasks.. 194. 2015
Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance?. 195. 2015
ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy.. 194. 2015
Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer.. 194. 2015
Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active Surveillance.. 194. 2015
Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.. 194. 2015
Disparities in the Use of Sacral Neuromodulation among Medicare Beneficiaries.. 194. 2015
Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.. 194. 2015
Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma.. 194. 2015
Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.. 194. 2015
The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer Landscape.. 194. 2015
Prostate cancer risk estimation tool use by members of the American Urological Association: a survey based study.. 193. 2015
Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.. 193. 2014
Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.. 193. 2014
Comparison of baseline urological symptoms in men and women in the MAPP research cohort.. 193. 2014
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.. 193. 2014
Renal cell carcinoma in children, adolescents and young adults: a National Cancer Database study.. 193. 2014
Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP study.. 193. 2014
Efficacy and safety of MCNA in patients with nonmuscle invasive bladder cancer at high risk for recurrence and progression after failed treatment with bacillus Calmette-Guérin.. 193. 2014
A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomy.. 193. 2014
Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.. 193. 2014
Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.. 193. 2014
Usefulness of transurethral biopsy for staging the prostatic urethra before radical cystectomy.. 193. 2014
Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.. 193. 2014
Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma.. 193. 2014
The risk of urinary tract infection after flexible cystoscopy in patients with bladder tumor who did not receive prophylactic antibiotics.. 193. 2014
Robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients.. 192. 2014
Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failure.. 192. 2014
Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancer.. 193. 2014
Risk of chronic and end stage kidney disease in patients with nephrolithiasis.. 192. 2014
Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.. 192. 2014
Prospective external validation of a bladder cancer detection model.. 192. 2014
Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis.. 192. 2014
Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology.. 192. 2014
Functional magnetic resonance imaging during urodynamic testing identifies brain structures initiating micturition.. 192. 2014
Resource utilization and costs associated with the diagnostic evaluation of nonrefluxing primary hydronephrosis in infants.. 192. 2014
Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening.. 192. 2014
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.. 192. 2014
Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer.. 192. 2014
Clinical outcomes of local and metastatic testicular sex cord-stromal tumors.. 192. 2014
Identification of spermatogenesis in a rat sertoli-cell only model using Raman spectroscopy: a feasibility study.. 192. 2014
Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.. 192. 2014
Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?. 192. 2014
Relating economic conditions to vasectomy and vasectomy reversal frequencies: a multi-institutional study.. 191. 2014
Use of a preoperative checklist reduces risk of penile prosthesis infection.. 192. 2013
Risk factors for the development of parastomal hernia after radical cystectomy.. 191. 2013
The prevalence of persistent prostate cancer after radiotherapy detected at radical cystoprostatectomy for bladder cancer.. 191. 2013
Inflammatory response to Escherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host.. 191. 2013
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.. 191. 2013
The association between statin medication and progression after surgery for localized renal cell carcinoma.. 191. 2013
Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery.. 191. 2013
Changes in pelvic organ prolapse surgery in the last decade among United States urologists.. 191. 2013
A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy.. 191. 2013
BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma.. 191. 2013
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.. 191. 2013
Relationship between C-reactive protein and kidney stone prevalence.. 191. 2013
Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?. 191. 2013
Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.. 191. 2013
Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer.. 191. 2013
The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance.. 191. 2013
Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer.. 191. 2013
Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder.. 191. 2013
The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.. 191. 2013
Microsurgical rat varicocele model.. 191. 2013
Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis.. 191. 2013
Impact of the 2012 American Urological Association vasectomy guidelines on post-vasectomy outcomes.. 191. 2013
Severe testicular atrophy does not affect the success of microdissection testicular sperm extraction.. 191. 2013
Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.. 191. 2013
Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma.. 190. 2013
Use of surveillance imaging following treatment of small renal masses.. 190. 2013
Image based feasibility of renal sparing surgery for very low risk unilateral Wilms tumors: a report from the Children's Oncology Group.. 190. 2013
Risk of incisional hernia after minimally invasive and open radical prostatectomy.. 190. 2013
Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer.. 190. 2013
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure.. 190. 2013
Perioperative celecoxib decreases opioid use in patients undergoing testicular surgery: a randomized, double-blind, placebo controlled trial.. 190. 2013
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.. 190. 2013
Functional status and postoperative morbidity in older women with prolapse.. 190. 2013
Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists.. 190. 2013
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.. 190. 2013
Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.. 190. 2013
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy.. 190. 2013
Urine neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after kidney surgery.. 190. 2013
Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.. 190. 2013
A multi-institutional evaluation of active surveillance for low risk prostate cancer.. 189. 2013
A comparison of models for predicting sperm retrieval before microdissection testicular sperm extraction in men with nonobstructive azoospermia.. 189. 2012
Localization of sperm during microdissection testicular sperm extraction in men with nonobstructive azoospermia.. 189. 2012
Renal calyceal anatomy characterization with 3-dimensional in vivo computerized tomography imaging.. 189. 2012
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.. 189. 2012
Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States.. 189. 2012
Sex disparities in cancer mortality: the risks of being a man in the United States.. 189. 2012
Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.. 189. 2012
Clinically significant prostate cancer is rarely missed by ablative procedures of the prostate in men with prostate specific antigen less than 4 ng/ml.. 189. 2012
Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device.. 189. 2012
The surgical learning curve of artificial urinary sphincter implantation: implications for prosthetic training and referral.. 189. 2012
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.. 189. 2012
Preoperative accuracy of diagnostic evaluation of the urachal mass.. 189. 2012
Influence of surgeon and hospital volume on radical prostatectomy costs.. 188. 2012
Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer.. 189. 2012
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach.. 189. 2012
Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.. 188. 2012
Improvement in overall survival of patients with advanced renal cell carcinoma: prognostic factor trend analysis from an international data set of clinical trials.. 188. 2012
Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade.. 189. 2012
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer.. 188. 2012
Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis.. 189. 2012
Transperineal management for postoperative and radiation rectourethral fistulas.. 189. 2012
Urinary diversion practice patterns among certifying American urologists.. 189. 2012
How dry is "OAB-dry"? Perspectives from patients and physician experts.. 188. 2012
Long-term durability of the distal urethral polypropylene sling for the treatment of stress urinary incontinence: minimum 11-year followup.. 188. 2012
Stepwise description and outcomes of bladder neck sparing during robot-assisted laparoscopic radical prostatectomy.. 188. 2012
Correlation of magnetic resonance imaging tumor volume with histopathology.. 188. 2012
National trends and disparities in the use of minimally invasive adult pyeloplasty.. 188. 2012
Factors associated with the adoption of minimally invasive radical prostatectomy in the United States.. 188. 2012
Prostate biopsy in response to a change in nadir prostate specific antigen of 0.4 ng/ml after treatment with 5α-reductase inhibitors markedly enhances the detection rate of prostate cancer.. 188. 2012
Pilot study of the correlation of multiphoton tomography of ex vivo human testis with histology.. 188. 2012
Role of optimizing testosterone before microdissection testicular sperm extraction in men with nonobstructive azoospermia.. 188. 2012
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.. 188. 2012
Outcomes of endoscopic realignment of pelvic fracture associated urethral injuries at a level 1 trauma center.. 188. 2012
Surgical practice patterns for male urinary incontinence: analysis of case logs from certifying American urologists.. 188. 2012
Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.. 188. 2012
Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States.. 187. 2012
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT.. 187. 2012
Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series.. 187. 2012
Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality.. 187. 2012
Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy.. 187. 2012
Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery.. 187. 2012
Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy.. 187. 2012
Discharge patterns after radical cystectomy: contemporary trends in the United States.. 187. 2012
Complex artificial urinary sphincter revision and reimplantation cases--how do they fare compared to virgin cases?. 187. 2012
Recovery of urinary function after radical prostatectomy: predictors of urinary function on preoperative prostate magnetic resonance imaging.. 187. 2012
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.. 187. 2012
Zero ischemia anatomical partial nephrectomy: a novel approach.. 187. 2012
Multiphoton imaging and laser ablation of rodent spermatic cord nerves: potential treatment for patients with chronic orchialgia.. 187. 2011
Corpus cavernosum electromyography revisited: defining the origin of the signal.. 187. 2011
Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy.. 187. 2011
Intravesical bacillus Calmette-Guérin outcomes in patients with bladder cancer and asymptomatic bacteriuria.. 187. 2011
Nomograms to predict patency after microsurgical vasectomy reversal.. 187. 2011
Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation.. 187. 2011
Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.. 187. 2011
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers.. 187. 2011
Global evaluative assessment of robotic skills: validation of a clinical assessment tool to measure robotic surgical skills.. 187. 2011
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.. 187. 2011
Amelioration of renal ischemia-reperfusion injury with a novel protective cocktail.. 186. 2011
Identification of spermatogenesis with multiphoton microscopy: an evaluation in a rodent model.. 186. 2011
Laparoendoscopic single site live donor nephrectomy: single institution report of initial 100 cases.. 186. 2011
Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.. 186. 2011
Comparison of complications of laparoscopic versus laparoendoscopic single site donor nephrectomy using the modified Clavien grading system.. 186. 2011
Comparison of outpatient narcotic prescribing patterns after minimally invasive versus retropubic and perineal radical prostatectomy.. 186. 2011
Radical prostatectomy at academic versus nonacademic institutions: a population based analysis.. 186. 2011
Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner.. 186. 2011
17α-Estradiol and genistein inhibit high fat diet induced prostate gene expression and prostate growth in the rat.. 186. 2011
Early versus late maturation arrest: reproductive outcomes of testicular failure.. 186. 2011
Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia.. 186. 2011
Selective arterial embolization of angiomyolipomas: a comparison of smaller and larger embolic agents.. 186. 2011
Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.. 186. 2011
Routine drain placement after partial nephrectomy is not always necessary.. 186. 2011
Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma.. 186. 2011
Use of empiric antibiotics in the setting of an increased prostate specific antigen: pro.. 186. 2011
Cold intravascular organ perfusion for renal hypothermia during laparoscopic partial nephrectomy.. 185. 2011
Implantation of artificial urinary sphincter in patients with post-prostatectomy incontinence, and preoperative overactive bladder and mixed symptoms.. 185. 2011
Increased follicle-stimulating hormone is associated with higher assisted reproduction use after vasectomy reversal.. 185. 2011
A plea for a uniform surveillance schedule after radical cystectomy.. 185. 2011
Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy.. 185. 2011
Selective arterial embolization for pseudoaneurysms and arteriovenous fistula of renal artery branches following partial nephrectomy.. 185. 2011
The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.. 185. 2011
Molecular effects of genistein on male urethral development.. 185. 2011
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).. 185. 2011
Overuse of imaging for staging low risk prostate cancer.. 185. 2011
Duration of microdissection testicular sperm extraction procedures: relationship to sperm retrieval success.. 185. 2011
Intraoperative conversion from partial to radical nephrectomy at a single institution from 2003 to 2008.. 185. 2011
Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy.. 185. 2011
Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder.. 185. 2011
Successful repeat microdissection testicular sperm extraction in men with nonobstructive azoospermia.. 185. 2011
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.. 185. 2011
Renal oncocytosis: management and clinical outcomes.. 185. 2011
Inhibition of aberrant androgen receptor induction of prostate specific antigen gene expression, cell proliferation and tumor growth by 17α-estradiol in prostate cancer.. 185. 2011
Older age is associated with similar improvements in semen parameters and testosterone after subinguinal microsurgical varicocelectomy.. 185. 2010
Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma.. 185. 2010
Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function.. 185. 2010
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer.. 185. 2010
Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer.. 185. 2010
Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.. 185. 2010
Diagnosis of the gr/gr Y chromosome microdeletion does not help in the treatment of infertile American men.. 185. 2010
Microsurgical spermatocelectomy: technique and outcomes of a novel surgical approach.. 185. 2010
Chronic kidney disease before and after partial nephrectomy.. 185. 2010
Comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy.. 185. 2010
Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases.. 185. 2010
Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials.. 185. 2010
An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy.. 184. 2010
Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends.. 184. 2010
Concordance of near infrared spectroscopy with pressure flow studies in men with lower urinary tract symptoms.. 184. 2010
The learning curve for laparoscopic radical prostatectomy: an international multicenter study.. 184. 2010
Laparoendoscopic single site live donor nephrectomy: initial experience.. 184. 2010
Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.. 184. 2010
Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy.. 184. 2010
Gating of sensory information differs in patients with interstitial cystitis/painful bladder syndrome.. 184. 2010
No-needle local anesthesia for adult male circumcision.. 184. 2010
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.. 184. 2010
Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.. 184. 2010
Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.. 184. 2010
Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.. 184. 2010
Clinical outcome of primary versus secondary bladder carcinoma in situ.. 184. 2010
Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.. 184. 2010
pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.. 184. 2010
Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?. 183. 2010
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients.. 183. 2010
Impact of prior prostate radiation on complications after radical prostatectomy.. 184. 2010
Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy.. 184. 2010
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.. 184. 2010
Outcomes of laparoscopic donor nephrectomy without intraoperative systemic heparinization.. 183. 2010
Urethral diverticula in women: discrepancies between magnetic resonance imaging and surgical findings.. 183. 2010
Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.. 183. 2010
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.. 183. 2010
Complications after radical and partial nephrectomy as a function of age.. 183. 2010
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.. 183. 2010
Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes.. 183. 2010
Comprehensive 5-year study of cytogenetic aberrations in 668 infertile men.. 183. 2010
Decreasing electrosurgical transurethral resection of the prostate surgical volume during graduate medical education training is associated with increased surgical adverse events.. 183. 2010
How do you tell whether a change in surgical technique leads to a change in outcome?. 183. 2010
Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.. 183. 2010
Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.. 183. 2010
Small incidentally discovered testicular masses in infertile men--is active surveillance the new standard of care?. 183. 2010
The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point.. 183. 2010
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection.. 183. 2010
Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates.. 183. 2010
Variations among experienced surgeons in cancer control after open radical prostatectomy.. 183. 2010
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients.. 183. 2010
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.. 183. 2010
Renal insufficiency is an independent risk factor for complications after partial nephrectomy.. 183. 2010
Low annual caseloads of United States surgeons conducting radical prostatectomy.. 182. 2009
Conditional survival predictions after nephrectomy for renal cell carcinoma.. 182. 2009
Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors.. 182. 2009
Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy.. 182. 2009
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.. 182. 2009
Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma.. 182. 2009
Ureteroileocecal appendicostomy based urinary reservoir in irradiated and nonirradiated patients.. 182. 2009
Validating the incontinence symptom severity index: a self-assessment instrument for voiding symptom severity in women.. 182. 2009
Clinical presentation and urachal remnant pathology: implications for treatment.. 182. 2009
Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer.. 182. 2009
Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer.. 182. 2009
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.. 182. 2009
Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.. 182. 2009
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.. 182. 2009
Bosniak category IIF designation and surgery for complex renal cysts.. 182. 2009
Successful fertility treatment for Klinefelter's syndrome.. 182. 2009
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.. 182. 2009
Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical prostatectomy.. 182. 2009
p53 predictive value for pT1-2 N0 disease at radical cystectomy.. 182. 2009
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.. 182. 2009
Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.. 182. 2009
A population based assessment of perioperative mortality after cystectomy for bladder cancer.. 182. 2009
Metastatic renal cell carcinoma risk according to tumor size.. 182. 2009
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.. 182. 2009
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.. 181. 2009
Temporal trends in adoption of and indications for the artificial urinary sphincter.. 181. 2009
Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.. 181. 2009
Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat.. 181. 2009
Tumor size is associated with malignant potential in renal cell carcinoma cases.. 181. 2009
A multi-institutional evaluation of active surveillance for low risk prostate cancer.. 181. 2009
S1P/S1P2 signaling induces cyclooxygenase-2 expression in Wilms tumor.. 181. 2009
Contemporary use of partial nephrectomy at a tertiary care center in the United States.. 181. 2009
Surgical apgar outcome score: perioperative risk assessment for radical cystectomy.. 181. 2009
Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria.. 181. 2008
Antagonism of BMP4 signaling disrupts smooth muscle investment of the ureter and ureteropelvic junction.. 181. 2008
Value of serum antisperm antibodies in diagnosing obstructive azoospermia.. 181. 2008
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?. 181. 2008
Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.. 180. 2008
Patterns of care for radical prostatectomy in the United States from 2003 to 2005.. 180. 2008
Photoselective vaporization of the prostate using a laser high performance system in the canine model.. 180. 2008
Renal cell carcinoma in young and old patients--is there a difference?. 180. 2008
External validation of the updated Partin tables in a cohort of North American men.. 180. 2008
Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma.. 180. 2008
The effect of concomitant prolapse repair on sling outcomes.. 180. 2008
The outcome of intracytoplasmic sperm injection using occasional spermatozoa in the ejaculate of men with spermatogenic failure.. 180. 2008
Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.. 180. 2008
Positive surgical margins at partial nephrectomy: predictors and oncological outcomes.. 179. 2008
Incidental testicular lesions found during infertility evaluation are usually benign and may be managed conservatively.. 180. 2008
Varicocelectomy for male infertility: a comparative study of open, laparoscopic and microsurgical approaches.. 180. 2008
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.. 179. 2008
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.. 179. 2008
Preoperative nomogram predicting 12-year probability of metastatic renal cancer.. 179. 2008
Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.. 179. 2008
Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.. 179. 2008
Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005.. 179. 2008
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.. 179. 2008
Establishing the prevalence of incontinence study: racial differences in women's patterns of urinary incontinence.. 179. 2008
Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer.. 179. 2008
Results of vasovasostomy or vasoepididymostomy after failed percutaneous epididymal sperm aspirations.. 179. 2008
Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.. 179. 2008
Sexual function and quality of life in the male partner of infertile couples: prevalence and correlates of dysfunction.. 179. 2008
The pathophysiology of large capacity bladder.. 179. 2008
Revision washout decreases implant capsule tissue culture positivity: a multicenter study.. 179. 2007
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.. 179. 2007
Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.. 179. 2007
A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer.. 178. 2007
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.. 178. 2007
Sunitinib efficacy against advanced renal cell carcinoma.. 178. 2007
Urogenital disorders associated with gut failure and intestinal transplantation.. 178. 2007
Nerve sparing ventral clitoroplasty preserves dorsal nerves in congenital adrenal hyperplasia.. 178. 2007
Association of procedure volume with radical cystectomy outcomes in a nationwide database.. 178. 2007
Esthetic outcomes of genitoplasty in males born with bladder exstrophy and epispadias.. 178. 2007
Nerve sparing ventral clitoroplasty: analysis of clitoral sensitivity and viability.. 178. 2007
The role of preoperative testing on outcomes after sling surgery for stress urinary incontinence.. 178. 2007
Variations in stress incontinence and prolapse management by surgeon specialty.. 178. 2007
Management of low grade papillary bladder tumors.. 178. 2007
Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.. 178. 2007
Castration resistant, taxane naïve metastatic prostate cancer: current clinical approaches and future directions.. 178. 2007
Uniform testicular maturation arrest: a unique subset of men with nonobstructive azoospermia.. 178. 2007
Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.. 178. 2007
Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.. 178. 2007
A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization.. 177. 2007
Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.. 177. 2007
Bilateral caudal epidural neuromodulation for refractory urinary retention: a salvage procedure.. 177. 2007
Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.. 177. 2007
Is sildenafil citrate associated with an amelioration of the symptomatology of androgen decline in the aging male?. 177. 2007
Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors.. 177. 2007
Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.. 178. 2007
Urachal carcinoma: contemporary surgical outcomes.. 178. 2007
Racial disparities in the surgical management of stress incontinence among female Medicare beneficiaries.. 177. 2007
Hunter Holmes McGuire and the coffee pot spout procedure.. 177. 2007
Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.. 177. 2007
Interferon-alpha resistance associated genes in renal cell carcinoma identified by expression profiling.. 177. 2007
Microdissection testicular sperm extraction: effect of prior biopsy on success of sperm retrieval.. 177. 2007
The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies.. 177. 2007
The role of provider volume on outcomes after sling surgery for stress urinary incontinence.. 177. 2007
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.. 177. 2007
Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.. 177. 2007
13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine.. 177. 2007
Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.. 177. 2007
Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.. 177. 2007
Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach.. 177. 2007
Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience.. 177. 2007
Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development.. 177. 2007
Ignorance is bliss: the Listerian revolution and education of American surgeons.. 177. 2007
Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.. 177. 2007
The anterior layer of Denonvilliers' fascia: a common misconception in the laparoscopic prostatectomy literature.. 177. 2007
Bladder necrosis following hydrodistention in patients with interstitial cystitis.. 177. 2007
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?. 177. 2007
Predicting the histology of renal masses using preoperative Doppler ultrasonography.. 177. 2007
Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex.. 176. 2006
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.. 176. 2006
Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.. 176. 2006
Adult genitourinary sarcoma: the 25-year Memorial Sloan-Kettering experience.. 176. 2006
Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis.. 176. 2006
Microsurgical reconstruction of iatrogenic injuries to the epididymis from hydrocelectomy.. 176. 2006
Natural history of positive urinary cytology after radical cystectomy.. 176. 2006
Percutaneous computerized tomography guided cryoablation for localized renal cell carcinoma: factors influencing success.. 176. 2006
The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination survey.. 176. 2006
Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma.. 176. 2006
Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway.. 176. 2006
Max Nitze, the cystoscope and urology.. 176. 2006
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.. 176. 2006
Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function.. 176. 2006
Percutaneous computerized tomography guided renal cryoablation using local anesthesia: pain assessment.. 176. 2006
Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading.. 176. 2006
Protective effects of plasma carotenoids on the risk of bladder cancer.. 176. 2006
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.. 176. 2006
Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction.. 176. 2006
Comparison of the Q-tip test and voiding cystourethrogram to assess urethral hypermobility among women enrolled in a randomized clinical trial of surgery for stress urinary incontinence.. 176. 2006
Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.. 176. 2006
Prognostic nomogram for renal insufficiency after radical or partial nephrectomy.. 176. 2006
Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings.. 176. 2006
Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.. 176. 2006
Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.. 176. 2006
Prior circumcision does not complicate repair of hypospadias with an intact prepuce.. 176. 2006
An analysis of the natural history of Peyronie's disease.. 175. 2006
Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract.. 175. 2006
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.. 175. 2006
Failure of sacral nerve stimulation due to migration of tined lead.. 175. 2006
Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins.. 175. 2006
Cancer specific outcomes in patients with pT0 disease following radical cystectomy.. 175. 2006
Spiral sling salvage anti-incontinence surgery in female patients with a nonfunctional urethra: technique and initial results.. 175. 2006
Efficacy and safety of histrelin subdermal implant in patients with advanced prostate cancer.. 175. 2006
The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.. 175. 2006
Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.. 175. 2006
Biological correlates of p27 compartmental expression in prostate cancer.. 175. 2006
Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience.. 175. 2006
Long-term durability of the distal urethral polypropylene sling procedure for stress urinary incontinence: minimum 5-year followup of surgical outcome and satisfaction determined by patient reported questionnaires.. 175. 2006
Perioperative complications of laparoscopic and robotic assisted laparoscopic radical prostatectomy.. 175. 2006
Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.. 175. 2006
Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner.. 175. 2006
Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.. 174. 2005
Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.. 174. 2005
Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.. 174. 2005
Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996-2000.. 174. 2005
Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis.. 174. 2005
Kidney paired donation and optimizing the use of live donor organs.. 174. 2005
Processed lipoaspirate cells for tissue engineering of the lower urinary tract: implications for the treatment of stress urinary incontinence and bladder reconstruction.. 174. 2005
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.. 174. 2005
Quality of care: partial cystectomy for bladder cancer--a case of inappropriate use?. 174. 2005
Radiation exposure and the urologist: what are the risks?. 174. 2005
Anatomy of accessory pudendal arteries in laparoscopic radical prostatectomy.. 174. 2005
Health issues of men: prevalence and correlates of erectile dysfunction.. 174. 2005
Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma.. 174. 2005
Outcome and late failures compared in 4 techniques of microsurgical vasoepididymostomy in 153 consecutive men.. 174. 2005
Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup.. 174. 2005
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.. 174. 2005
Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: experience in 107 patients.. 174. 2005
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.. 173. 2005
Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.. 173. 2005
Ethnic background has minimal impact on the etiology of nephrolithiasis.. 173. 2005
Testosterone as a predictor of pathological stage in clinically localized prostate cancer.. 173. 2005
The natural history of chronic allograft nephropathy.. 173. 2005
Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.. 173. 2005
Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer.. 173. 2005
Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?. 173. 2005
No-needle jet anesthetic technique for no-scalpel vasectomy.. 173. 2005
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.. 173. 2005
Legacy of Edwin Beer: fulguration of papillary bladder tumors.. 173. 2005
Urethral injuries in the Civil War.. 173. 2005
Incidence and postoperative outcomes of accidental ligation of the testicular artery during microsurgical varicocelectomy.. 173. 2005
Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation.. 173. 2005
Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.. 173. 2005
A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.. 173. 2005
Revision washout decreases penile prosthesis infection in revision surgery: a multicenter study.. 173. 2005
c-kit and ureteral peristalsis.. 173. 2005
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.. 172. 2004
Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy.. 172. 2004
Results of 265 consecutive proximal hypospadias repairs using the Thiersch-Duplay principle.. 172. 2004
Race is not a predictor of prostate cancer detection on repeat prostate biopsy.. 172. 2004
The presence of vasal vessels in men with congenital bilateral absence of the vas deferens.. 172. 2004
Urological injuries in the Civil War.. 172. 2004
Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.. 172. 2004
Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis.. 172. 2004
Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review.. 172. 2004
Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection.. 172. 2004
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.. 172. 2004
Toward a sutureless vasovasostomy: use of biomaterials and surgical sealants in a rodent vasovasostomy model.. 172. 2004
Botulinum toxin type A: a novel approach to the treatment of recurrent urethral strictures.. 172. 2004
Intravasal "toothpaste" in men with obstructive azoospermia is derived from vasal epithelium, not sperm.. 172. 2004
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. 172. 2004
When can persistent hydroureteronephrosis in posterior urethral valve disease be considered residual stretching?. 172. 2004
Does Valsalva leak point pressure predict outcome after the distal urethral polypropylene sling? Role of urodynamics in the sling era.. 172. 2004
Hand assisted laparoscopic training for postgraduate urologists: the role of mentoring.. 172. 2004
The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.. 171. 2004
Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening.. 171. 2004
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.. 171. 2004
Predictors of prostate cancer after initial negative systematic 12 core biopsy.. 171. 2004
Radio frequency ablation of small renal tumors:: intermediate results.. 171. 2004
Stage specific lymph node metastasis mapping in radical cystectomy specimens.. 171. 2004
Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report.. 171. 2004
An analysis of men with clinically localized prostate cancer who deferred definitive therapy.. 171. 2004
Impact of unnecessary exploratory laparotomy on the treatment of patients with metastatic germ cell tumor.. 171. 2004
Robotic microsurgical vasovasostomy and vasoepididymostomy: a prospective randomized study in a rat model.. 171. 2004
Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.. 171. 2004
Ketorolac: safe and effective analgesia for the management of renal cortical tumors with partial nephrectomy.. 171. 2004
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.. 171. 2004
Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology.. 171. 2004
Dietary L-arginine supplementation improves the glomerular filtration rate and renal blood flow after 24 hours of unilateral ureteral obstruction in rats.. 171. 2004
Do concerns about more advanced pathological features increase the likelihood of neurovascular bundle resection in black men undergoing radical prostatectomy?. 171. 2004
Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm.. 171. 2004
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.. 171. 2004
Is year of radical prostatectomy a predictor of outcome in prostate cancer?. 171. 2004
Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival.. 171. 2004
Predicting quality of life after radical prostatectomy: results from CaPSURE.. 171. 2004
Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.. 171. 2004
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.. 171. 2004
Complications of radical and partial nephrectomy in a large contemporary cohort.. 171. 2004
Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.. 171. 2004
The impact of obstructive interval and sperm granuloma on outcome of vasectomy reversal.. 171. 2004
Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.. 171. 2004
Intraoperative varicocele anatomy: a microscopic study of the inguinal versus subinguinal approach.. 170. 2003
Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy.. 170. 2003
The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer.. 170. 2003
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.. 170. 2003
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.. 170. 2003
Carcinoma in a bladder diverticulum: presentation and treatment outcome.. 170. 2003
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.. 170. 2003
Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer.. 170. 2003
Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.. 170. 2003
Postmortem sperm retrieval: the effect of instituting guidelines.. 170. 2003
Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen.. 170. 2003
A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session.. 170. 2003
A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results.. 170. 2003
Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging.. 170. 2003
Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors.. 170. 2003
Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis.. 170. 2003
Testicular sperm extraction with intracytoplasmic sperm injection is successful for the treatment of nonobstructive azoospermia associated with cryptorchidism.. 170. 2003
Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.. 170. 2003
Prospective analysis of patients treated with a distal urethral polypropylene sling for symptoms of stress urinary incontinence: surgical outcome and satisfaction determined by patient driven questionnaires.. 170. 2003
Radical prostatectomy nomograms in black American men: accuracy and applicability.. 170. 2003
Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001.. 169. 2003
Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy.. 169. 2003
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.. 169. 2003
Regret in men treated for localized prostate cancer.. 169. 2003
Defining bacillus Calmette-Guerin refractory superficial bladder tumors.. 169. 2003
Microsurgical vasoepididymostomy: a prospective randomized study of 3 intussusception techniques in rats.. 169. 2003
Voiding patterns in patients with post-prostatectomy incontinence: urodynamic and demographic analysis.. 169. 2003
Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction.. 169. 2003
Temporal trends in radical prostatectomy complications from 1991 to 1998.. 169. 2003
Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.. 169. 2003
Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?. 169. 2003
Superiority of ratio based lymph node staging for bladder cancer.. 169. 2003
Ten-year experience with transvaginal vesicovaginal fistula repair using tissue interposition.. 169. 2003
Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy.. 169. 2003
Effect of hormonal manipulation on mRNA expression of antioxidant enzymes in the rat testis.. 169. 2003
The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen.. 169. 2003
Androgen receptor gene polyglutamine length is associated with testicular histology in infertile patients.. 169. 2003
Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence.. 169. 2003
Pleural injury during laparoscopic renal surgery: early recognition and management.. 169. 2003
Renal hemodynamic and ureteral pressure changes in response to ureteral obstruction: the role of nitric oxide.. 169. 2003
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.. 168. 2002
Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder.. 168. 2002
Men with nonobstructive azoospermia have Leydig cell hypertrophy but not hyperplasia.. 168. 2002
Ultrasound guided needle localization and microsurgical exploration for incidental nonpalpable testicular tumors.. 168. 2002
Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging.. 168. 2002
Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome.. 168. 2002
High intensity focused ultrasound ablation of the vas deferens in a canine model.. 167. 2002
Comparison of intussusception pull-through end-to-side and conventional end-to-side microsurgical vasoepididymostomy: prospective randomized controlled study in male wistar rats.. 167. 2002
Cross-linked matrix tissue sealant protects against mortality and hemorrhage in an acute renal injury model in heparinized rats.. 167. 2002
Osteotesticular protein tyrosine phosphatase expression in rodent testis.. 167. 2002
The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial.. 167. 2002
Treatment of chronic prostatitis lowers serum prostate specific antigen.. 167. 2002
Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.. 167. 2002
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.. 167. 2002
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.. 167. 2002
Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.. 167. 2002
Prostate cancer screening with prostate specific antigen in spinal cord injured men.. 167. 2002
Aromatase inhibitors for male infertility.. 167. 2002
Artificial urinary sphincter for post-prostatectomy incontinence in men who had prior radiotherapy: a risk and outcome analysis.. 167. 2002
Cancer control with radical prostatectomy alone in 1,000 consecutive patients.. 167. 2002
Diethylstilbesterol revisited: androgen deprivation, osteoporosis and prostate cancer.. 167. 2002
Evaluation of octylcyanoacrylate for wound repair of clinical circumcision and human skin incisional healing in a nude rat model.. 167. 2002
Paracolic recurrence: the importance of wide excision of the spermatic cord at retroperitoneal lymph node dissection.. 167. 2002
Fibroblast growth factor-7 regulates stratification of the bladder urothelium.. 166. 2001
Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.. 166. 2001
Improvement in emotional well-being and relationships of users of sildenafil.. 166. 2001
Pressure flow measurement of hydronephrosis in children: a new approach to definition and quantification of obstruction.. 166. 2001
Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra.. 166. 2001
Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?. 166. 2001
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.. 166. 2001
Magnetic resonance imaging for the evaluation of hydronephrosis, reflux and renal scarring in children.. 166. 2001
A postoperative prognostic nomogram for renal cell carcinoma.. 166. 2001
Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup.. 165. 2001
Outpatient flexible cystoscopy in men: a randomized study of patient tolerance.. 165. 2001
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.. 165. 2001
Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer.. 165. 2001
Pubovaginal sling using cadaveric fascia and bone anchors: disappointing early results.. 165. 2001
The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer.. 165. 2001
Cystectomy for bladder cancer: a contemporary series.. 165. 2001
Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance.. 165. 2001
Evidence of a treatable endocrinopathy in infertile men.. 165. 2001
Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer.. 165. 2001
Combined stent and artificial urinary sphincter for management of severe recurrent bladder neck contracture and stress incontinence after prostatectomy: a long-term evaluation.. 165. 2001
Evaluation of sonographic renal parenchymal area in the management of hydronephrosis.. 165. 2001
Tensile strength of cadaveric fascia lata compared to small intestinal submucosa using suture pull through analysis.. 165. 2001
Mechanism of healing following the Snodgrass repair.. 165. 2001
Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.. 165. 2001
Factors predicting recovery of erections after radical prostatectomy.. 164. 2000
Video urodynamic findings in men with the central cord syndrome.. 164. 2000
Interaction of nitric oxide and transforming growth factor-beta1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells.. 164. 2000
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.. 164. 2000
1999 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care.. 164. 2000
Cytokine variations in patients with hormone treated prostate cancer.. 164. 2000
Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.. 164. 2000
Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.. 164. 2000
Urodynamics in spinal cord injured patients walking with reciprocating gait orthosis.. 164. 2000
BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation.. 163. 2000
Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.. 163. 2000
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.. 163. 2000
Treatment of infertility due to anejaculation in the male with electroejaculation and intracytoplasmic sperm injection.. 163. 2000
A clinical series of laparoscopic nephrectomy, nephroureterectomy and heminephroureterectomy in the pediatric population.. 163. 2000
Microsurgical testis biopsy: a novel technique for retrieval of testicular tissue.. 163. 2000
The plug and patch: a new technique for repair of corporal perforation during placement of penile prostheses.. 163. 2000
An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.. 163. 2000
Removal of UroLume endoprosthesis: experience of the North American Study Group for detrusor-sphincter dyssynergia application.. 163. 2000
Surgical management of renal tumors 4 cm. or less in a contemporary cohort.. 163. 2000
Testis biopsy findings in the spinal cord injured patient.. 163. 2000
Assessment of the degradation of denatured albumin solder by human urine.. 163. 2000
Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.. 163. 2000
Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome.. 163. 2000
The dispute about the external sphincter and the urogenital diaphragm.. 162. 1999
1998 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of ureteral stones and impact of managed care.. 162. 1999
Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversion.. 162. 1999
Sildenafil citrate after radical retropubic prostatectomy.. 162. 1999
Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation.. 162. 1999
Immune response in patients with persistent candiduria and occult candidemia.. 162. 1999
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.. 162. 1999
Prognostic factors for long-term renal function in boys with the prune-belly syndrome.. 162. 1999
Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model.. 162. 1999
Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?. 162. 1999
FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation.. 162. 1999
Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma.. 162. 1999
BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy.. 162. 1999
Comparison of bilateral versus unilateral varicocelectomy in men with palpable bilateral varicoceles.. 162. 1999
Helical computerized tomography arteriography for evaluation of live renal donors undergoing laparoscopic nephrectomy.. 162. 1999
The value of a second transurethral resection in evaluating patients with bladder tumors.. 162. 1999
Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group.. 161. 1999
Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome.. 161. 1999
Function of M3 muscarinic receptors in the rat urinary bladder following partial outlet obstruction.. 161. 1999
Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia.. 161. 1999
The effects of mesh bioprosthesis on the spermatic cord structures: a preliminary report in a canine model.. 161. 1999
Antibacterial skin preparation decreases the incidence of false-positive semen culture results.. 161. 1999
Preperitoneal prosthetic mesh hernioplasty during radical retropubic prostatectomy.. 161. 1999
Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology.. 161. 1999
Pelvic lymph node dissection can be curative in patients with node positive bladder cancer.. 161. 1999
A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia.. 161. 1999
Analysis of homeobox gene HOXA10 mutations in cryptorchidism.. 161. 1999
Can p53 help select patients with invasive bladder cancer for bladder preservation?. 161. 1999
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.. 161. 1999
Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup.. 161. 1999
Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.. 161. 1999
Real-time transesophageal echocardiography for intraoperative surveillance of patients with renal cell carcinoma and vena caval extension undergoing radical nephrectomy.. 161. 1999
Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia: testicular histology can predict success of sperm retrieval.. 161. 1999
The impact of primary stage on survival in patients with lymph node positive bladder cancer.. 161. 1999
Management of impending penile prosthesis erosion with a polytetrafluoroethylene distal wind sock graft.. 160. 1998
Preoperative screening for genetic abnormalities in men with nonobstructive azoospermia before testicular sperm extraction.. 160. 1998
1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997.. 160. 1998
Decreased elastin gene expression in noncompliant human bladder tissue: a competitive reverse transcriptase-polymerase chain reaction analysis.. 160. 1998
Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary?. 160. 1998
Multiple primary malignancies in renal cell carcinoma.. 160. 1998
Androgen receptor gene alterations are not associated with isolated cryptorchidism.. 160. 1998
Tolerability of high energy transurethral microwave thermotherapy with topical urethral anesthesia: results of a prospective, randomized, single-blinded clinical trial.. 160. 1998
Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen: long-term followup.. 160. 1998
Prostate specific antigen density of the transition zone for early detection of prostate cancer.. 160. 1998
A serous lined antireflux valve: in vivo fluorourodynamic evaluation of antireflux continence mechanism.. 160. 1998
Microsurgical repair of the adolescent varicocele.. 160. 1998
Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure.. 160. 1998
Evaluation of new resectoscope loop for transurethral resection of bladder tumors.. 159. 1998
The T pouch: an orthotopic ileal neobladder incorporating a serosal lined ileal antireflux technique.. 159. 1998
Clinical stage I testis cancer: long-term outcome of patients on surveillance.. 159. 1998
Low p27 expression predicts poor disease-free survival in patients with prostate cancer.. 159. 1998
The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis.. 159. 1998
The use of bladder for total transplant ureteral reconstruction.. 159. 1998
The value of unenhanced helical computerized tomography in the management of acute flank pain.. 159. 1998
Subspecialization, recruitment and retirement trends of American urologists.. 159. 1998
Microsurgical repair of iatrogenic injury to the vas deferens.. 159. 1998
Microsurgical vasovasostomy: the microdot technique of precision suture placement.. 159. 1998
The role of oxybutynin in spinal cord injured patients with indwelling catheters.. 158. 1997
Apoptotic frequency is increased in spermatogenic maturation arrest and hypospermatogenic states.. 158. 1997
Influence of hepatic function on serum levels of prostate specific antigen.. 158. 1997
A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer.. 158. 1997
Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model.. 158. 1997
Transrectal prostate ultrasonography: variability of interpretation.. 158. 1997
Ureteral carcinoma in situ at radical cystectomy: does the margin matter?. 158. 1997
Cu/Zn superoxide dismutase, catalase and glutathione peroxidase mRNA expression in the rat testis after surgical cryptorchidism and efferent duct ligation.. 158. 1997
Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?. 157. 1997
Immunostimulatory therapy with anti-CD3 monoclonal antibodies and recombinant interleukin-2: heightened in vivo expression of mRNA encoding cytotoxic attack molecules and immunoregulatory cytokines and regression of murine renal cell carcinoma.. 157. 1997
Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.. 157. 1997
Molecular staging of prostate cancer. III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay.. 157. 1997
Comparison of fibrin glue, laser weld, and mechanical suturing device for the laparoscopic closure of ureterotomy in a porcine model.. 157. 1997
Microsurgical reconstruction following failed vasectomy reversal.. 157. 1997
Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial.. 157. 1997
Doxazosin for benign prostatic hyperplasia: long-term efficacy and safety in hypertensive and normotensive patients. The Multicenter Study Group.. 157. 1997
Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue.. 157. 1997
Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions.. 156. 1996
Electromotive drug administration to the urinary bladder: an animal model and preliminary results.. 156. 1996
Telesurgical consultation.. 156. 1996
Upper tract tumors in patients with primary bladder cancer followed for 15 years.. 156. 1996
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.. 156. 1996
Use of an anti-ras ribozyme to alter the malignant phenotype of a human bladder cancer cell line.. 156. 1996
Androgen receptor gene mutations are rarely associated with isolated penile hypospadias.. 156. 1996
Human cytomegalovirus is not implicated in benign prostatic hyperplasia: a study using immunohistochemistry and the polymerase chain reaction.. 156. 1996
Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer.. 156. 1996
Early identification of candiduria by polymerase chain reaction in high risk patients.. 156. 1996
Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis.. 156. 1996
Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes.. 155. 1996
Urogenital anomalies in men with congenital absence of the vas deferens.. 155. 1996
Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy.. 155. 1996
Laparoscopic orchiopexy: clinical experience and description of technique.. 155. 1996
Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.. 155. 1996
Presence of sperm in the pre-vasectomy reversal semen analysis: incidence and implications.. 155. 1996
Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results.. 154. 1995
Patency following microsurgical vasoepididymostomy and vasovasostomy: temporal considerations.. 154. 1995
Radical retropubic prostatectomy: limited benefit of autologous blood donation.. 154. 1995
A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.. 154. 1995
Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced bladder cancer overview collaboration.. 154. 1995
Prognostic significance of positive surgical margins in radical prostatectomy specimens.. 154. 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.. 154. 1995
The effect of varicocelectomy on serum testosterone levels in infertile men with varicoceles.. 154. 1995
The effect of zanoterone, a steroidal androgen receptor antagonist, in men with benign prostatic hyperplasia. The Zanoterone Study Group.. 154. 1995
Pelvic lymph node histiocytosis mimicking metastatic prostatic adenocarcinoma: association with hip prostheses.. 154. 1995
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer.. 154. 1995
LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of BCG therapy.. 154. 1995
Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.. 154. 1995
A simple ileal substitute bladder after radical cystectomy: experience with a modification of the Studer pouch.. 153. 1995
TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49.. 153. 1995
Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction.. 153. 1995
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5 year follow-up.. 153. 1995
Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.. 153. 1995
Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues.. 152. 1994
Neurotrophic factors in the rat penis.. 152. 1994
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.. 152. 1994
Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer.. 152. 1994
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma.. 152. 1994
Multicenter trial in North America of UroLume urinary sphincter prosthesis.. 152. 1994
A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer.. 152. 1994
Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.. 152. 1994
High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.. 152. 1994
Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.. 152. 1994
Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer.. 151. 1994
Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis.. 151. 1994
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.. 151. 1994
Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma.. 151. 1994
Results in the United States with sperm microaspiration retrieval techniques and assisted reproductive technologies. The Sperm Microaspiration Retrieval Techniques Study Group.. 151. 1994
Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features.. 151. 1994
Myocutaneous flaps in genitourinary oncology.. 151. 1994
Neuroendocrine differentiation in metastatic prostatic adenocarcinoma.. 151. 1994
Impotence and chronic renal failure: a study of the hemodynamic pathophysiology.. 151. 1994
Quality of life of incontinent men after radical prostatectomy.. 151. 1994
Flutamide-induced testicular undescent in the rat is associated with alterations in genitofemoral nerve morphology.. 151. 1994
Urachal carcinoma: the case for extended partial cystectomy.. 151. 1994
Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma.. 150. 1993
Major renal lacerations with a devitalized fragment following blunt abdominal trauma: a comparison between nonoperative (expectant) versus surgical management.. 150. 1993
Urological evaluation and management of renal-proximity stab wounds.. 150. 1993
Microsurgical vasoepididymostomy: refinements and results.. 150. 1993
Possible mechanism for seeding of tumor during radical prostatectomy.. 150. 1993
Chromophore enhanced laser welding of canine ureters in vitro using a human protein solder: a preliminary step for laparoscopic tissue welding.. 150. 1993
Effect of atrial natriuretic peptide on urine flow and glomerular filtration during acute renal allograft rejection.. 150. 1993
Patch graft urethroplasty using dye enhanced laser tissue welding with a human protein solder: a preclinical canine model.. 150. 1993
Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors.. 150. 1993
The development of tumors in experimental gastroenterocystoplasty.. 150. 1993
Transdermal dihydrotestosterone therapy and its effects on patients with microphallus.. 150. 1993
Management of low velocity gunshot wounds to the anterior urethra: the role of primary repair versus urinary diversion alone.. 150. 1993
Ureteropelvic junction disruption following blunt abdominal trauma.. 150. 1993
Posttraumatic impotence: magnetic resonance imaging and duplex ultrasound in diagnosis and management.. 149. 1993
Relationship between varicocele size and response to varicocelectomy.. 149. 1993
Studies of the hormonal control of postnatal testicular descent in the rat.. 149. 1993
Treatment of brain metastases from bladder cancer.. 149. 1993
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors.. 148. 1992
Microsurgical inguinal varicocelectomy with delivery of the testis: an artery and lymphatic sparing technique.. 148. 1992
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.. 148. 1992
Intraoperative varicocele anatomy: a macroscopic and microscopic study.. 148. 1992
Magnetic resonance imaging of traumatic posterior urethral defects and pelvic crush injuries.. 148. 1992
Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer.. 148. 1992
Postpubertal genitourinary function following posterior urethral disruptions in children.. 148. 1992
Angiographic embolization of renal stab wounds.. 148. 1992
Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens.. 148. 1992
Radiographic evaluation of adult patients with blunt renal trauma.. 148. 1992
Optimal parameters for CO2 laser reconstruction of urethral tissue using a protein solder.. 148. 1992
Prostatic and periprostatic interstitial temperature measurements in patients treated with transrectal thermal therapy (local intracavitary microwave hyperthermia).. 147. 1992
Adult urological sarcoma.. 147. 1992
Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup.. 147. 1992
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer.. 147. 1992
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.. 147. 1992
Management of local bacillus Calmette-Guerin failures in superficial bladder cancer.. 147. 1992
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group.. 147. 1992
Detection and staging of prostatic carcinoma after transurethral resection or open enucleation of the prostate: accuracy of magnetic resonance imaging.. 147. 1992
Detection of human papillomavirus in squamous neoplasm of the penis.. 147. 1992
The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer.. 146. 1991
DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder.. 146. 1991
A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate.. 146. 1991
The risk of dying of prostate cancer in patients with clinically localized disease.. 146. 1991
Transrectal ultrasonography in stage A prostate cancer: detection of residual tumor after transurethral resection of prostate.. 146. 1991
An improved method for computerized tomography-planned transperineal 125iodine prostate implants.. 146. 1991
Subclinical varicocele: the effectiveness of varicocelectomy.. 145. 1991
The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer.. 145. 1991
The no-scalpel vasectomy.. 145. 1991
Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin.. 145. 1991
Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors.. 144. 1990
Technique of left adrenalectomy for autotransplantation to the caudate nucleus in Parkinson's disease.. 144. 1990
125iodine reimplantation for locally progressive prostatic carcinoma.. 144. 1990
Urethrectomy with preservation of potency.. 144. 1990
Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.. 144. 1990
Prostatomembranous urethral disruptions: management by suprapubic cystostomy and delayed urethroplasty.. 144. 1990
Suprapubic approach for bilateral orchiectomy and placement of testicular prostheses.. 143. 1990
The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin.. 143. 1990
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation.. 143. 1990
Infrequent ras oncogene point mutations in renal cell carcinoma.. 143. 1990
Urethral reconstruction using the carbon dioxide laser: an experimental evaluation.. 142. 1989
Elevation of intratesticular and scrotal skin surface temperature in men with varicocele.. 142. 1989
The urological manifestations of the acquired immunodeficiency syndrome.. 142. 1989
Mortality in pediatric paratesticular rhabdomyosarcoma: a multivariate analysis.. 142. 1989
Prognostic significance of lymph nodal metastases in prostate cancer.. 142. 1989
The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer.. 142. 1989
Risk factors for perineal seeding of prostate cancer after needle biopsy.. 142. 1989
The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations.. 142. 1989
Candidal antigenemia: a prognostic determinant.. 141. 1989
Characterization and localization of in vivo phospholipid methylation in the hamster testis.. 141. 1989
Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin.. 141. 1989
Detection of testicular endocrine abnormalities and their correlation with serum antisperm antibodies in men following vasectomy.. 141. 1989
Cytotoxicity of high energy shock waves: methodologic considerations.. 141. 1989
Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra.. 141. 1989
Neuroanatomy of the pelvis in an infant with cloacal exstrophy: a detailed microdissection with histology.. 141. 1989
Primary signet ring cell adenocarcinoma of the bladder.. 141. 1989
Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.. 141. 1989
Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin).. 140. 1988
Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study.. 140. 1988
Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate.. 140. 1988
Men with congenital absence of the vas deferens often have seminal vesicles.. 140. 1988
Correction of severe penile curves with tunica albuginea autografts.. 139. 1988
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.. 139. 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.. 139. 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.. 139. 1988
Laser welding in urethral surgery: improved results with a protein solder.. 139. 1988
Free radical production by high energy shock waves--comparison with ionizing irradiation.. 139. 1988
Miconazole: a cost-effective antifungal genitourinary irrigant.. 138. 1987
Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function.. 138. 1987
Conservative management of muscle-infiltrating bladder cancer: prospective experience.. 138. 1987
Initial experience with extracorporeal shock wave lithotripsy in children.. 138. 1987
Magnetic resonance imaging in genital anomalies.. 138. 1987
Monitoring endoscopic treatment of superficial bladder carcinoma by postoperative urinary cytology.. 138. 1987
Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology.. 138. 1987
Identification of "tumor-associated" nucleolar antigens in human urothelial cancer.. 138. 1987
Ureteral carcinoma in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management.. 138. 1987
Fertility status of patients with clinical stage I testis tumors on a surveillance protocol.. 138. 1987
Development and characterization of a monoclonal antibody to human embryonal carcinoma.. 137. 1987
Simultaneous preperitoneal hernia repair during radical pelvic surgery.. 137. 1987
Penile cancer: relation of extent of nodal metastasis to survival.. 137. 1987
Endocrine and exocrine profiles of men with testicular tumors before orchiectomy.. 137. 1987
The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction.. 137. 1987
Histopathologic and ultrastructural correlates of tumor growth suppression by high energy shock waves.. 137. 1987
Assessment of clinical renal preservation by phosphorus-31 magnetic resonance spectroscopy.. 137. 1987
Assessment of renal preservation by phosphorus-31 magnetic resonance spectroscopy: in vivo normothermic blood perfusion.. 136. 1986
Effect of thromboxane inhibition on renal blood flow in dogs with complete unilateral ureteral obstruction.. 136. 1986
Predictors of eventual end stage renal disease in children with posterior urethral valves.. 136. 1986
The prevalence of 5 alpha-reductase deficiency in children with ambiguous genitalia in the Dominican Republic.. 136. 1986
Sertoli cell production of müllerian inhibiting substance in vitro.. 136. 1986
Assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy.. 135. 1986
Scrotal ultrasound in the infertile man: detection of subclinical unilateral and bilateral varicoceles.. 135. 1986
Functional evaluation of penile veins by cavernosography in papaverine-induced erection.. 135. 1986
High energy shock waves suppress tumor growth in vitro and in vivo.. 135. 1986
Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection.. 135. 1986
The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer.. 135. 1986
Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.. 135. 1986
Scrotal temperature reflects intratesticular temperature and is lowered by shaving.. 135. 1986
The effect of graded unilateral testicular biopsy on the reproductive capacity of male rats.. 135. 1986
Human renal cell carcinoma xenograft: morphology, growth and chemosensitivities.. 134. 1985
Urolithiasis and race: another viewpoint.. 134. 1985
Microspike approximator for vasovasostomy.. 134. 1985
Renal trauma: evaluation by computerized tomography.. 133. 1985
Monitoring intravesical bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometry.. 133. 1985
Transrectal ultrasonography for prostatic cancer: its value in staging and monitoring the response to radiotherapy and chemotherapy.. 133. 1985
Vinblastine and methotrexate for advanced bladder cancer.. 133. 1985
Immunohistologic dissection of the human kidney using monoclonal antibodies.. 133. 1985
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.. 133. 1985
Selective pre-transplant nephrectomy: indications and perioperative management.. 133. 1985
Do the imidazoles have a role in the management of genitourinary fungal infections?. 133. 1985
Treatment of genitourinary rhabdomyosarcoma in children.. 132. 1984
Sarcomas of the kidney.. 132. 1984
Phase II trial of doxorubicin in bidimensionally measurable prostatic adenocarcinoma.. 131. 1984
Prophylactic antibiotics and Foley catheter use in transperineal needle biopsy of the prostate.. 131. 1984
Inguinal lymph node metastases from germ cell testicular tumors.. 131. 1984
Correction of adult penile curvature with a Nesbit operation.. 131. 1984
Renal cell carcinoma extending into inferior vena cava.. 130. 1983
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer.. 129. 1983
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area.. 129. 1983
Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney.. 129. 1983
Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer.. 128. 1982
Amphotericin B as a urologic irrigant in the management of noninvasive candiduria.. 128. 1982
Flow cytometry followup of patients with low stage bladder tumors.. 128. 1982
Flow cytometry of normal and nonneoplastic diseases of the bladder: an estimate of the false positive rate.. 127. 1982
Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.. 127. 1982
Adherent suppressor cells in the blood of patients with bladder cancer.. 126. 1981
A nosocomial epidemic of antibiotic-resistant Serratia marcescens urinary tract infections.. 124. 1980
Flucytosine in the management of genitourinary candidiasis: 5 years of experience.. 124. 1980
Cis-diamminedichloride platinum II in the treatment of advanced bladder cancer.. 123. 1980
Suppressor cells in immunodepressed bladder and prostate cancer patients.. 123. 1980
Flow cytometry in bladder cancer detection and evaluation using acridine orange metachromatic nucleic acid staining of irrigation cytology specimens.. 123. 1980
Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.. 123. 1980
Experience with flutamide in previously untreated patients with advanced prostatic cancer.. 122. 1979
Malignancy in uremia: dialysis versus transplantation.. 121. 1979
Preservation of sexual potency in prostatic cancer patients after pelvic lymphadenectomy and retropubic 125I implantation.. 121. 1979
Spermatic cord sarcoma in adults.. 120. 1978
Use of a caliper to determine dimensions of the volume to be implanted with 125iodine in the treatment of prostatic carcinoma.. 120. 1978
Fertility problems in the renal transplant patient.. 118. 1977
The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.. 118. 1977
Ureterosigmoidostomy.. 118. 1977
Genitourinary candidiasis: diagnosis and treatment.. 116. 1976
Phenoxybenzamine in the management of neurogenic vesical dysfunction.. 116. 1976
Prognostic significance of regional lymph node histology in cancer of the bladder.. 115. 1976
Semen cultures in the diagnosis of bacterial prostatitis.. 114. 1975
Factor IX deficiency in the nephrotic syndrome: studies with prothrombin complex concentrate.. 113. 1975
Family study of vesicoureteral reflux.. 113. 1975
Intermittent catheterization in neurogenic bladder dysfunction.. 113. 1975
External sphincterotomy in traumatic and non-traumatic neurogenic bladder dysfunction.. 113. 1975
Management of inguinal lymph nodes in patients with testicular tumors following orchiopexy, inguinal or scrotal operations.. 110. 1973
Injuries associated with renal trauma.. 109. 1973
Use of prophylactic antibiotics in the high-risk patient undergoing prostatectomy: effect on morbidity.. 109. 1973
Transient significant bacteriuria in women.. 109. 1973
Unsuspected primary cortical renal cell carcinoma presenting as a metastatic subepithelial pelvic filling defect.. 109. 1973
Complete vertical cleft of the glans penis.. 108. 1972
The serodiagnosis of significant genitourinary candidiasis.. 107. 1972
Evidence against a vesicorenal reflex.. 107. 1972
Urinary retention associated with herpes zoster.. 104. 1970
Tissue culture of human renal cell carcinoma: effect of serum on monolayer growth.. 103. 1970
Panel discussion: medicolegal aspects of urology.. 81. 1959
Tobacco Screening and Treatment during Outpatient Urology Office Visits in the United States. Letter.J Urol 2021; 205: 1755.. 206. 2021
Editorial Comment.. 206. 2021
Editorial Comment.. 204. 2020
Editorial Comment.. 204. 2020
Reply by Authors.. 204. 2020
Reply by Authors.. 204. 2020
Editorial Comment.. 203. 2020
Editorial Comment.. 203. 2019
Reply by Authors.. 203. 2019
Reply by Authors.. 202. 2019
Reply by Authors.. 202. 2019
Editorial Comment.. 202. 2019
Re: Marijuana Use in Transplantation: A Call for Clarity.. 202. 2019
Re: Surgical Approach Does Not Impact Margin Status after Partial Nephrectomy for Large Renal Masses.. 202. 2019
Reply by Authors.. 202. 2019
Eliminating Early Surgery for Disorders of Sex Development: Risking Adverse Outcomes in 46, XX CAH.. 201. 2019
Re: Impact of Ureteral Stricture and Treatment Choice on Long-Term Graft Survival in Kidney Transplantation.. 201. 2019
Re: Dopamine in Transplantation: .. 201. 2019
Re: Potential Yield of Imminent Death Kidney Donation.. 200. 2018
Re: Shipping Living Donor Kidneys and Transplant Recipient Outcomes.. 200. 2018
Re: Recent Changes in Prostate Cancer Screening Practices and Epidemiology: D. J. Lee, K. Mallin, A. J. Graves, S. S. Chang, D. F. Penson, M. J. Resnick and D. A. Barocas J Urol 2017;198:1230-1240.. 199. 2018
Re: Urologic Malignancies in Kidney Transplantation.. 199. 2018
Re: Use and Outcomes of Kidneys from Donation after Circulatory Death Donors in the United States.. 199. 2018
Re: Robot-Assisted Kidney Transplantation: The European Experience.. 199. 2018
Re: Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.. 199. 2018
Re: New Insights into the Alleged Kidney Donor Profile Index Labeling Effect on Kidney Utilization.. 199. 2018
Editorial Comment.. 199. 2017
Editorial Comment.. 199. 2017
Editorial Comment.. 199. 2017
Re: A Cost Comparison for Telehealth Utilization in the Kidney Transplant Waitlist Evaluation Process.. 198. 2017
Re: Telemedically Supported Case Management of Living-Donor Renal Transplant Recipients to Optimize Routine Evidence-Based Aftercare: A Single-Center Randomized Controlled Trial.. 198. 2017
Re: Big Data, Predictive Analytics, and Quality Improvement in Kidney Transplantation: A Proof of Concept.. 198. 2017
Re: Remote Ischemic Conditioning on Recipients of Deceased Renal Transplants Does Not Improve Early Graft Function: A Multicenter Randomized, Controlled Clinical Trial.. 198. 2017
Re: Continuous Normothermic Ex Vivo Kidney Perfusion is Superior to Brief Normothermic Perfusion following Static Cold Storage in Donation after Circulatory Death Pig Kidney Transplantation.. 198. 2017
Editorial Comment.. 198. 2017
Editorial Comment.. 198. 2017
Editorial Comment.. 198. 2017
Re: Eight-Hour Continuous Normothermic Ex Vivo Kidney Perfusion is a Safe Preservation Technique for Kidney Transplantation: A New Opportunity for the Storage, Assessment, and Repair of Kidney Grafts.. 197. 2017
Re: Coronary Calcium Score May Replace Cardiovascular Risk Factors as Primary Risk Stratification Tool before Kidney Transplantation.. 197. 2017
The Camey Procedure.. 197. 2016
Editorial Comment.. 196. 2016
Editorial Comment.. 196. 2016
Editorial Comment.. 196. 2016
Re: Live Donor Renal Transplant with Simultaneous Bilateral Nephrectomy for Autosomal Dominant Polycystic Kidney Disease is Feasible and Satisfactory at Long-Term Follow-up.. 196. 2016
Re: Obstetric and Neonatal Outcome of Pregnancies Fathered by Males on Immunosuppression after Solid Organ Transplantation.. 195. 2015
Re: ABO Incompatible Renal Transplantation without Antibody Removal Using Conventional Immunosuppression Alone.. 194. 2015
Re: frailty and early hospital readmission after kidney transplantation.. 191. 2014
Re: a single-center analysis of abdominal imaging in the evaluation of kidney transplant recipients.. 191. 2014
Re: impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: M. Hagiwara, E. Kikuchi, N. Tanaka, K. Matsumoto, H. Ide, A. Miyajima, T. Masuda, S. Nakamura and M. Oya J Urol 2013; 189: 2062-2068.. 191. 2013
Re: Renal transplantation after ex vivo normothermic perfusion: the first clinical study.. 190. 2013
Re: Debilitating lower urinary tract symptoms in the post-renal transplant population can be predicted pretransplantation.. 190. 2013
Re: early hospital readmission after kidney transplantation: patient and center-level associations.. 190. 2013
Re: de novo kidney graft tumors: results from a multicentric retrospective national study.. 190. 2013
Re: Value of routine voiding cystourethrography after renal transplantation.. 189. 2013
Re: long-term results of biopsy-guided selection and allocation of kidneys from older donors in older recipients.. 189. 2013
Re: Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure.. 189. 2013
Re: kidney transplant ureteroneocystostomy: comparison of full-thickness vs. Lich-Gregoir techniques.. 189. 2012
Re: pulsatile pump decreases risk of delayed graft function in kidneys donated after cardiac death.. 189. 2012
Re: A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.. 188. 2012
Re: Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation.. 188. 2012
Re: Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis.. 188. 2012
Re: Current status of organ transplantation in Japan.. 188. 2012
Re: A simplified donor risk index for predicting outcome after deceased donor kidney transplantation.. 188. 2012
Re: Influence of CIT-induced DGF on kidney transplant outcomes.. 188. 2012
Re: Renovascular resistance of machine-perfused DCD kidneys is associated with primary non-function.. 188. 2012
Re: donor kidney adapts to body dimensions of recipient: no influence of donor gender on renal function after transplantation.. 187. 2012
Re: the prognostic value of renal resistance during hypothermic machine perfusion of deceased donor kidneys.. 187. 2012
Re: desensitization in HLA-incompatible kidney recipients and survival.. 187. 2012
Re: first in man renal transplantation after ex vivo normothermic perfusion.. 187. 2012
Re: effect of obesity on the outcome of kidney transplantation: a 20-year follow-up.. 187. 2011
Re: laparoscopic kidney transplantation: an initial experience.. 187. 2011
Re: Native nephrectomy for renal cell carcinoma in transplant recipients.. 186. 2011
Re: Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis.. 186. 2011
Re: Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes.. 186. 2011
Editorial comment.. 185. 2011
Renal transplantation and renovascular hypertension.. 184. 2010
Re: Artificial urinary sphincter in children-voiding or emptying? An evaluation of functional results in 44 patients M. Catti, S. Lortat-Jacob, M. Morineau and H. Lottmann J Urol 2008; 180: 690-693.. 181. 2009
Re: Editorial comment. R. J. Kallen. J Urol 2007; 178: 1047.. 180. 2008
Laparoscopic live donor nephrectomy: a risk factor for delayed function and rejection in pediatric kidney recipients? A UNOS analysis.. 174. 2005
Donor kidney exchanges.. 173. 2005
Re: Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. 173. 2005
Tissue engineering stem cells, and cloning: opportunities for regenerative medicine.. 173. 2005
Current recommendations for delaying renal transplantation after localized prostate cancer treatment: are they still appropriate?. 173. 2005
Re: acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.. 173. 2005
Stented versus nonstented extravesical ureteroneocystostomy in renal transplantation: a metaanalysis.. 173. 2005
Ureteral necrosis after kidney transplantation: risk factors and impact on graft and patient survival.. 173. 2005
Death in the first year after kidney transplantation: implications for patients on the transplant waiting list.. 170. 2003
Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation?. 170. 2003
Prevalence of renovascular disease in the elderly: a population-based study.. 170. 2003
Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies.. 170. 2003
Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.. 170. 2003
Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors.. 169. 2003
Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.. 169. 2003
Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database.. 169. 2003
Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too.. 169. 2003
Use of heparin and protamine sulfate during laparoscopic donor nephrectomy.. 169. 2003
Re: Corporoplasty using tunica albuginea free grafts for penile curvature: surgical technique and long-term results.. 168. 2002
Are wound complications after a kidney transplant more common with modern immunosuppression?. 168. 2002
Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury.. 168. 2002
Kidney transplantation in children weighing less than 15 kg: donor selection and technical considerations.. 168. 2002
Nonsurgical treatment of acute iatrogenic renal artery injuries occurring after renal artery angioplasty and stenting.. 168. 2002
Pancreas after kidney transplants.. 168. 2002
Re: laparoscopic radical nephrectomy: cancer control for renal cell carcinoma.. 168. 2002
Genetic alterations in prostate cancer.. 162. 1999
This month in investigative urology: Round spermatid nuclei and embryonic development.. 158. 1997
Re: Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy.. 152. 1994
Re: Accuracy of ultrasound diagnosis after blunt testicular trauma.. 152. 1994
Re: Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma.. 152. 1994
Re: The no-scalpel vasectomy.. 148. 1992
Re: Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.. 138. 1987
Re: Ketoconazole therapy for fungal urinary tract infections.. 131. 1984
Re: in vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.. 127. 1982
Cleft glans penis.. 121. 1979
Editorial Comment. 2024
Reply by Authors. 2021
Reply by Authors. 2021
Reply by Authors. 2021
Reply by Authors. 2020
Editorial Comment. 2019
Re: Unhealthy Behaviors among Canadian Men are Predictors of Comorbidities: . 2019
Reply by Authors. 2018
Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update. 2013
Against: The case for cytoreductive nephrectomy for the management of metastatic renal cell carcinoma. 2009
Re: A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative TRUS-Biopsy with Long-Term Follow-Up. 2022
Re: Editorial comment. D. A. Canning, J Urol 2006; 176: 2242. 2007
Highlights from the Society of Urologic Oncology, 5th Annual Meeting, December 3-4, 2004, Bethesda, Maryland, United States of America. 2005
Highlights from the Society of Urologic Oncology 4th annual meeting. 2005
Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment. 2004
Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment. 2003
PAE for BPH. 2024
Editorial Comment.. 208. 2022
Preoperative Testosterone for Hypospadias: What's the Goal? 2022
Editorial Comment.. 206. 2021
Understanding the True Prevalence of Prostate Cancer Genomic Subtypes: Use of Inverse Probability Weighting to Correct for Biases in Molecularly Profiled Cohorts.. 205. 2021
Urology Chief Resident Turned Medicine Intern: Experience during the COVID-19 New York City Pandemic.. 204. 2020
The Most Important Lesson I Learned this Year.. 200. 2018
How to Decide Whether an Artificial Urinary Sphincter or a Male Sling is Best for Male Stress Urinary Incontinence.. 196. 2016
Are Some Cases of Somatic Type Malignancy Potentially Avoidable?. 196. 2016
Should Fluorescence Mapping be Used to Guide Pelvic Lymph Node Dissection?. 194. 2015
Re: Transplantation between monozygotic twins: how identical are they?. 193. 2014
Management of complications and residual symptoms in men with an artificial urinary sphincter.. 192. 2014
Novel urinary markers for detection of bladder cancer-are we failing?. 191. 2013
Evolution of novel biomarkers for detection of prostate cancer.. 190. 2013
Robotic salvage prostatectomy: underused but not for the inexperienced.. 189. 2012
Expectant management of localized prostate cancer--who, what, when, where and how?. 188. 2012
Assessing urological complications of radiation therapy and surgical approaches for repair.. 184. 2010
Female stress urinary incontinence--where are we?. 179. 2008
Low risk bladder tumors--less is more!. 179. 2007
When the quest for truth falters: the issue of scientific misconduct.. 179. 2007
Varicocele: size does matter.. 176. 2006
Ureteral obstruction and stents: still a difficult problem for patients and urologists alike.. 174. 2005
Percutaneous, image guided urological procedures: barbarians at the gate.. 174. 2005
A problem with a chaperone.. 173. 2005
Is less radical cystectomy better, and how can we be sure?. 173. 2005
Continuing refinements in radical prostatectomy: more evidence that technique matters.. 173. 2005
Editorial: predicting necrosis after chemotherapy for advanced nonseminomatous germ cell tumor-surrogate end points, decreasing morbidity and patient outcome.. 171. 2004
Editorial: hormone therapies for prostate cancer--acute disease control, chronic disease progression.. 169. 2003
Editorial: States and state transitions are all that really matter.. 168. 2002
Imaging prostate cancer.. 162. 1999
Towards a better crystal ball.. 160. 1998
New insights into the etiology and treatment of male infertility.. 158. 1997
Prostate cancer--staging and prognosis.. 155. 1996
Vasectomy and extracorporeal shock wave lithotripsy hurt-limit varicocelectomy procedures--To transurethral resection or not?. 155. 1996
Prostate cancer.. 154. 1995
Urinary reconstruction and diversion.. 154. 1995
Uncertainty, stage and outcome of invasive bladder cancer.. 152. 1994
Surgical therapy of male infertility.. 149. 1993
Intracavernous injection of vasoactive drugs after radical prostatectomy.. 139. 1988
Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis. 2019
Future Directions of Research and Care for Urinary Incontinence: Findings from the National Institute of Diabetes and Digestive and Kidney Diseases Summit on Urinary Incontinence Clinical Research in Women. 2017
Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction. 2016
Gleason 6 Prostate Cancer: Translating Biology into Population Health. 2015
Lynch Syndrome: A Primer for Urologists and Panel Recommendations. 2015
Urothelial carcinoma of the bladder and the upper tract: disparate twins. 2012
Oncological outcomes after radical cystectomy for bladder cancer: open versus minimally invasive approaches. 2010
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. 2007
Defining optimal therapy for muscle invasive bladder cancer. 2007
Bone health in men receiving androgen deprivation therapy for prostate cancer. 2007
Stem cell research: the facts, the myths and the promises. 2003
The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer. 2003
Cryopreservation of sperm: indications, methods and results. 2003
Understanding new genetics of male infertility. 2002
Systemic therapy for renal cell carcinoma. 2000
Is biopsy of the contralateral testis necessary in patients with germ cell tumors? 1997
Molecular biology and function of the androgen receptor in genital development. 1997
Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world. 1995
Carcinoma in situ of the bladder. 1995
The management of clinically unconfirmed positive urinary cytology. 1993
Amphotericin B in urological practice. 1990
An overview of intravesical therapy for superficial bladder tumors. 1987
Bilateral neonatal torsion. 1987
Magnetic resonance imaging in urology. 1984
Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis. 2023
Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis. 2021
Novel agents and approaches for advanced renal cell carcinoma. 2012
Contemporary applications and limitations of magnetic resonance imaging contrast materials. 2010
Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. 1998
Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. 1992

VIVO Weill Cornell Medical College

The Journal of urology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)